CD274 and neoplasm: Compared with the shortcomings of antibodies, such as large molecular weight, long half-life, and slow generation of high-contrast images, some current nonmonoclonal antibody PD-L1 small molecule ligands, including connexins, appendages, peptides, small proteins, and antibody fragments, may act as tracers with lower molecular weights, higher tumor uptake rates, and rapid clearance.